NM_207361.6(FREM2):c.6367T>C (p.Ser2123Pro) AND Fraser syndrome 2
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Jan 13, 2018
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001114005.4
Allele description [Variation Report for NM_207361.6(FREM2):c.6367T>C (p.Ser2123Pro)]
NM_207361.6(FREM2):c.6367T>C (p.Ser2123Pro)
Condition(s)
-
Homo sapiens fibroblast growth factor 23 (FGF23), RefSeqGene on chromosome 12
Homo sapiens fibroblast growth factor 23 (FGF23), RefSeqGene on chromosome 12gi|160358364|ref|NG_007087.1|Nucleotide
-
Homo sapiens Bardet-Biedl syndrome 1, mRNA (cDNA clone MGC:126184 IMAGE:40033834...
Homo sapiens Bardet-Biedl syndrome 1, mRNA (cDNA clone MGC:126184 IMAGE:40033834), complete cdsgi|80478085|gb|BC109065.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Jul 29, 2023